Results 251 to 260 of about 5,708,203 (270)
Some of the next articles are maybe not open access.
Molecular Pharmaceutics
Multivalent ligand strategy prevails recently in the design of radioligands for small-molecules due to its successes in enhancing the therapeutic efficacy of radiometallic ligands. In this work, 211At-FAPI-Dimer and 211At-APBA-FAPI-Dimer, two multivalent 211At-conjugated fibroblast activation protein inhibitors (FAPIs), were successfully synthesized ...
Tianzhen Ye +11 more
openaire +2 more sources
Multivalent ligand strategy prevails recently in the design of radioligands for small-molecules due to its successes in enhancing the therapeutic efficacy of radiometallic ligands. In this work, 211At-FAPI-Dimer and 211At-APBA-FAPI-Dimer, two multivalent 211At-conjugated fibroblast activation protein inhibitors (FAPIs), were successfully synthesized ...
Tianzhen Ye +11 more
openaire +2 more sources
(1229) Fibroblast Activation Protein Alpha (fapa) in Chronic Lung Allograft Dysfunction
The Journal of Heart and Lung Transplantation, 2023I. Moneke +8 more
openaire +1 more source
Compounds binding to fibroblast activation protein alpha
2023LEBEAU AARON M, HINTZ HALLIE M
openaire +1 more source
Inhibitors of fibroblast activation protein alpha
2009BACHOVCHIN WILLIAM W, LAI HUNG-SEN
openaire +2 more sources
ISOLATED DIMERIC FIBROBLAST ACTIVATION PROTEIN ALPHA, AND USES THEREOF
1997ZIMMERMANN RAINER +3 more
openaire +5 more sources
Proceedings of the National Academy of Sciences of the United States of America, 1994
W J Rettig, P Garin-Chesa, L J Old
exaly
W J Rettig, P Garin-Chesa, L J Old
exaly

